Vaccinex, Inc
- Biotech or pharma, therapeutic R&D
Vaccinex is a clinical-stage biotechnology company developing pepinemab, a semaphorin 4D (SEMA4D) blocking antibody, for the treatment of cancer and neurological disorders such as Alzheimer’s and Huntington’s disease. Additionally, Vaccinex has developed technologies to enable antibody discovery to complex antigens such as GPCRs using both in vitro and in vivo antibody discovery platforms.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}